Company / Assets per Share
VYNE Therapeutics Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.51
FY2025
5-year range
$1.55 / $30.25
FY2021-FY2025
Trend
-4.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 8 years, ranging from $1.55 in FY2021 to $30.25 in FY2023.
Based on SEC 10-K filings.
4.51 in FY2025 with a 5-year CAGR of -15.2%.
Declined from $30.25 to $4.51 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -30.9%
- 5-Year CAGR
- -15.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 4.9% year-over-year.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.51 | -4.9% |
| FY2024 | $4.75 | -84.3% |
| FY2023 | $30.25 | +120.9% |
| FY2022 | $13.69 | +782.4% |
| FY2021 | $1.55 | -84.9% |
| FY2020 | $10.28 | +201.6% |
| FY2019 | $3.41 | -87.1% |
| FY2018 | $26.41 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026